|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Raised circulating levels of atrial natriuritic peptides in essential hypertension显示文摘 | Sagenlla GA Markandu ND Shore AC | 1986 | Kancet1986，1，： | 1 |
| 2 | Long-term tolerability and efficacy of degarelix= 5-year results from a phase ]显示文摘 | Crawford ED Shore ND Moul JW | 2014 | Urology2014，83，5： | 1 |
| 3 | Raised circulating levels of atrial natriuretic peptides in essential hypertension 显示文摘 | Sagnella GA Markandu ND Shore AC | 1986 | Lancet1986，1，： | 1 |
| 4 | Building on sipuleucel-T for immunologic treatment of castration-resistant prostate cancer显示文摘 | Shore ND Mantz CA Dosoretz DE | 2013 | Cancer Control2013，20，1： | 1 |
| 5 | The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-abel, parallel- group phase Ill study in patients with prostate cancer 显示文摘 | Klotz L Boccon-Gibod L Shore ND | 2008 | BJU Int2008，102，11： | 1 |
| 6 | Sipuleucel-T immu- notherapy for castration - resistant prostate cancer 显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 7 | Sipuleucel-T im- munotherapy for castration-resistant prostate cancer显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 8 | Sipuleucel-T immuno therapy for castration-resistant prostate cancer 显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 9 | Sipuleucel-T immunotherapy for castration-resistant prostate cancer显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 10 | Sipuleucel - T immu- notherapy for castration - resistant prostate cancer 显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 11 | Advances in the understanding of cancer immunotherapy 显示文摘 | Shore ND | 2015 | BJU Int2015，116，3： | 1 |
| 12 | The efficacy andsafety of degarelix: a 12-month, comparative, randomized,open-label,parallel-group phase IE study in patients withprostate cancer显示文摘 | Klotz L Boccon-Gibod L Shore ND | 2008 | BJU Int2008，102，11： | 1 |
| 13 | Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies 显示文摘 | Crawford ED Higano CS Shore ND | 2015 | J Urol2015，194，6： | 1 |
| 14 | Sipuleucel-T immunotherapy for castrate-resistant prostate cancer显示文摘 | Kantoff PW Higano CS Shore ND | | 0，，： | 1 |
| 15 | New biomarkers in pros- tate cancer显示文摘 | Crawford ED Ventii K Shore ND | 2014 | Oncology2014，28，2： | 1 |
| 16 | The efficacy and safety of degarelix: a 12 - month comparative, randomized, open - label, parallel - group phase Ⅲ study in patients with prostate cancer 显示文摘 | Klotz L Boccon - Gibod L Shore ND | 2008 | BJU Int2008，102，11： | 1 |
| 17 | The efficacy and safe ty of dedarelix:a 12 month, comparative, vandomized open-label, parallel group phaseIII study in patients with prostate cancer显示文摘 | Klotz L Boccon-Gibod L Shore ND etal | 2008 | BJU Int2008，102，： | 1 |
| 18 | Sipuleucel-T Im-munotherapy for Castration-resistant prostate cancer显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 19 | Sipuleucel-T immunotherapy for castration-resistant prostate cancer显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
| 20 | Sipuleueel-T immunotherapy for castration-resistant prostate cancer 显示文摘 | Kantoff PW Higano CS Shore ND | 2010 | N Engl J Med2010，363，5： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员